Standout Papers
Immediate Impact
7 from Science/Nature 66 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Principles and therapeutic applications of adaptive immunity
2024 Standout
Works of Matthew J. Matasar being referenced
Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
2019 Standout
Outcomes of primary refractory diffuse large B‐cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Matthew J. Matasar | 2535 | 2271 | 873 | 180 | 3.7k | |
| Paul A. Hamlin | 2783 | 1998 | 891 | 153 | 3.8k | |
| Chan Y. Cheah | 2178 | 1608 | 1159 | 190 | 3.3k | |
| Jehan Dupuis | 3026 | 1711 | 884 | 114 | 4.0k | |
| John Sweetenham | 2698 | 2002 | 1446 | 138 | 4.5k | |
| Karim Belhadj | 2299 | 1588 | 760 | 97 | 3.5k | |
| Christophe Fermé | 3565 | 2370 | 1177 | 97 | 4.2k | |
| Luigi Rigacci | 3011 | 1537 | 780 | 138 | 3.9k | |
| Marcel Reiser | 2439 | 1856 | 1260 | 124 | 3.5k | |
| Catherine Sebban | 2265 | 1786 | 839 | 68 | 3.0k | |
| Francesco Merli | 3320 | 1782 | 846 | 156 | 4.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...